The medical treatment of patients with metastatic melanoma is undergoing rapid evolution due to advances in the field. Immunologic approaches to therapy constitute one major focus of our research program. Studies of cellular therapies for advanced disease, vaccine approaches, and gene therapy studies have all been investigated at the hospital. Recent advances in our understanding of the genetic causes of melanoma have led to a renewed enthusiasm in the second major research focus-therapies targeted at specific genetic lesions in melanoma. The use of small molecules to treat advanced melanoma holds great promise for the future of this field.

Visit the new cancer research website regarding ongoing clinical research in melanoma.